Pulmonary embolism in adolescent with COVID‐19 during aromatase inhibitor therapy
Sign Up to like & getrecommendations! Published in 2022 at "Pediatric Pulmonology"
DOI: 10.1002/ppul.25944
Abstract: Our case underlines the fact that pediatric patients with COVID-19 could be in risk of developing severe VTE, including PE, especially in the presence of underlying risk factors that enhance the thrombotic mechanisms of SARS-CoV-2.… read more here.
Keywords: aromatase inhibitor; embolism adolescent; pulmonary embolism; adolescent covid ... See more keywords